Trispecific antibodies offer a third way forward for anticancer immunotherapy

Alfred L. Garfall and Carl H. June ()

Nature, 2019, vol. 575, issue 7783, 450-451

Abstract: Immunotherapy approaches seek to boost immune responses against cancer. A single antibody engineered to recognize three targets shows promise, when tested in animals, in improving the ability of T cells to target cancer.

Keywords: Cancer; Immunology; Medical research (search for similar items in EconPapers)
Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-019-03495-3 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:575:y:2019:i:7783:d:10.1038_d41586-019-03495-3

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-019-03495-3

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().